Uptake, metabolism, and secretion of 3'-methyl-N,N-dimethyl-4-aminoazobenzene by isolated perfused rat liver

A. R. Samuels, L. Theilmann, Y. R. Stollman, Allan W. Wolkoff, M. M. Bhargava

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Uptake, metabolism, and biliary secretion of 3'-methyl-N,N-dimethyl-4-aminoazobenzene (3'-Me-DAB) were studied in isolated rat liver which was perfused with protein-free fluorocarbon medium. [14C]3'-Me-DAB (5-10 nmol) was injected into the portal vein and allowed to recirculate. The recovery of radioactivity in bile was 7.5, 14, and 20% at 15, 30, and 45 min of injection, respectively. At 45 min, the liver contained an additional 17% of injected radioactivity. Azo dye metabolites in perfused liver differed from those in vivo; metabolites co-migrating with 3'-CHO-DAB and 3'-methyl-n,n-methyl) aminoazobenzene (Me-MAB) (and the parent compound 3'-Me-DAB) were present, while metabolites co-migrating with 3'-Me-4'-OH-AB and 3'-CH2OH-MAB were increased and metabolites co-migrating with 3'-CH2OH-DAB were decreased. In bile from perfused liver, metabolites co-migrating with 3'-CHO-DAB and 3'-Me-DAB were undetectable. When proteins from normal bile were injected into the portal vein 15 min after the administration of 3'-Me-DAB, the compounds co-migrating with 3'-Me-MAB, 3'-CHO-DAB, 3'-Me-4'-OH-AB, and 3'-CH2OH-MAB decreased, and compounds co-migrating with 3'-CH2OH-DAB increased in the liver; in bile, there was an increase in 3'-Me-MAB, 3'-CHO-DAB, and 3'-Me-4'-OH-MAB, while there was a decrease in N-Ac-3'-Me-4'-OH-AB and 3'-COOH-DAB. Appearance of protein-metabolite adducts in bile were also observed after addition of normal bile proteins to the perfusate. The results suggest that uptake and metabolism of 3'-Me-DAB and biliary secretion of many of its metabolites occur in the absence of circulating blood protein; some metabolites may require proteins in the circulation for their secretion into bile.

Original languageEnglish (US)
Pages (from-to)184-188
Number of pages5
JournalDrug Metabolism and Disposition
Volume15
Issue number2
StatePublished - 1987
Externally publishedYes

Fingerprint

Metabolites
Metabolism
Bile
Liver
Rats
Portal Vein
Radioactivity
Proteins
Azo Compounds
Fluorocarbons
Serum-Free Culture Media
Blood Proteins
Injections
hydroxide ion
Recovery

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Uptake, metabolism, and secretion of 3'-methyl-N,N-dimethyl-4-aminoazobenzene by isolated perfused rat liver. / Samuels, A. R.; Theilmann, L.; Stollman, Y. R.; Wolkoff, Allan W.; Bhargava, M. M.

In: Drug Metabolism and Disposition, Vol. 15, No. 2, 1987, p. 184-188.

Research output: Contribution to journalArticle

Samuels, A. R. ; Theilmann, L. ; Stollman, Y. R. ; Wolkoff, Allan W. ; Bhargava, M. M. / Uptake, metabolism, and secretion of 3'-methyl-N,N-dimethyl-4-aminoazobenzene by isolated perfused rat liver. In: Drug Metabolism and Disposition. 1987 ; Vol. 15, No. 2. pp. 184-188.
@article{18ea33a9b011401fa63fa96fb474bb44,
title = "Uptake, metabolism, and secretion of 3'-methyl-N,N-dimethyl-4-aminoazobenzene by isolated perfused rat liver",
abstract = "Uptake, metabolism, and biliary secretion of 3'-methyl-N,N-dimethyl-4-aminoazobenzene (3'-Me-DAB) were studied in isolated rat liver which was perfused with protein-free fluorocarbon medium. [14C]3'-Me-DAB (5-10 nmol) was injected into the portal vein and allowed to recirculate. The recovery of radioactivity in bile was 7.5, 14, and 20{\%} at 15, 30, and 45 min of injection, respectively. At 45 min, the liver contained an additional 17{\%} of injected radioactivity. Azo dye metabolites in perfused liver differed from those in vivo; metabolites co-migrating with 3'-CHO-DAB and 3'-methyl-n,n-methyl) aminoazobenzene (Me-MAB) (and the parent compound 3'-Me-DAB) were present, while metabolites co-migrating with 3'-Me-4'-OH-AB and 3'-CH2OH-MAB were increased and metabolites co-migrating with 3'-CH2OH-DAB were decreased. In bile from perfused liver, metabolites co-migrating with 3'-CHO-DAB and 3'-Me-DAB were undetectable. When proteins from normal bile were injected into the portal vein 15 min after the administration of 3'-Me-DAB, the compounds co-migrating with 3'-Me-MAB, 3'-CHO-DAB, 3'-Me-4'-OH-AB, and 3'-CH2OH-MAB decreased, and compounds co-migrating with 3'-CH2OH-DAB increased in the liver; in bile, there was an increase in 3'-Me-MAB, 3'-CHO-DAB, and 3'-Me-4'-OH-MAB, while there was a decrease in N-Ac-3'-Me-4'-OH-AB and 3'-COOH-DAB. Appearance of protein-metabolite adducts in bile were also observed after addition of normal bile proteins to the perfusate. The results suggest that uptake and metabolism of 3'-Me-DAB and biliary secretion of many of its metabolites occur in the absence of circulating blood protein; some metabolites may require proteins in the circulation for their secretion into bile.",
author = "Samuels, {A. R.} and L. Theilmann and Stollman, {Y. R.} and Wolkoff, {Allan W.} and Bhargava, {M. M.}",
year = "1987",
language = "English (US)",
volume = "15",
pages = "184--188",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Uptake, metabolism, and secretion of 3'-methyl-N,N-dimethyl-4-aminoazobenzene by isolated perfused rat liver

AU - Samuels, A. R.

AU - Theilmann, L.

AU - Stollman, Y. R.

AU - Wolkoff, Allan W.

AU - Bhargava, M. M.

PY - 1987

Y1 - 1987

N2 - Uptake, metabolism, and biliary secretion of 3'-methyl-N,N-dimethyl-4-aminoazobenzene (3'-Me-DAB) were studied in isolated rat liver which was perfused with protein-free fluorocarbon medium. [14C]3'-Me-DAB (5-10 nmol) was injected into the portal vein and allowed to recirculate. The recovery of radioactivity in bile was 7.5, 14, and 20% at 15, 30, and 45 min of injection, respectively. At 45 min, the liver contained an additional 17% of injected radioactivity. Azo dye metabolites in perfused liver differed from those in vivo; metabolites co-migrating with 3'-CHO-DAB and 3'-methyl-n,n-methyl) aminoazobenzene (Me-MAB) (and the parent compound 3'-Me-DAB) were present, while metabolites co-migrating with 3'-Me-4'-OH-AB and 3'-CH2OH-MAB were increased and metabolites co-migrating with 3'-CH2OH-DAB were decreased. In bile from perfused liver, metabolites co-migrating with 3'-CHO-DAB and 3'-Me-DAB were undetectable. When proteins from normal bile were injected into the portal vein 15 min after the administration of 3'-Me-DAB, the compounds co-migrating with 3'-Me-MAB, 3'-CHO-DAB, 3'-Me-4'-OH-AB, and 3'-CH2OH-MAB decreased, and compounds co-migrating with 3'-CH2OH-DAB increased in the liver; in bile, there was an increase in 3'-Me-MAB, 3'-CHO-DAB, and 3'-Me-4'-OH-MAB, while there was a decrease in N-Ac-3'-Me-4'-OH-AB and 3'-COOH-DAB. Appearance of protein-metabolite adducts in bile were also observed after addition of normal bile proteins to the perfusate. The results suggest that uptake and metabolism of 3'-Me-DAB and biliary secretion of many of its metabolites occur in the absence of circulating blood protein; some metabolites may require proteins in the circulation for their secretion into bile.

AB - Uptake, metabolism, and biliary secretion of 3'-methyl-N,N-dimethyl-4-aminoazobenzene (3'-Me-DAB) were studied in isolated rat liver which was perfused with protein-free fluorocarbon medium. [14C]3'-Me-DAB (5-10 nmol) was injected into the portal vein and allowed to recirculate. The recovery of radioactivity in bile was 7.5, 14, and 20% at 15, 30, and 45 min of injection, respectively. At 45 min, the liver contained an additional 17% of injected radioactivity. Azo dye metabolites in perfused liver differed from those in vivo; metabolites co-migrating with 3'-CHO-DAB and 3'-methyl-n,n-methyl) aminoazobenzene (Me-MAB) (and the parent compound 3'-Me-DAB) were present, while metabolites co-migrating with 3'-Me-4'-OH-AB and 3'-CH2OH-MAB were increased and metabolites co-migrating with 3'-CH2OH-DAB were decreased. In bile from perfused liver, metabolites co-migrating with 3'-CHO-DAB and 3'-Me-DAB were undetectable. When proteins from normal bile were injected into the portal vein 15 min after the administration of 3'-Me-DAB, the compounds co-migrating with 3'-Me-MAB, 3'-CHO-DAB, 3'-Me-4'-OH-AB, and 3'-CH2OH-MAB decreased, and compounds co-migrating with 3'-CH2OH-DAB increased in the liver; in bile, there was an increase in 3'-Me-MAB, 3'-CHO-DAB, and 3'-Me-4'-OH-MAB, while there was a decrease in N-Ac-3'-Me-4'-OH-AB and 3'-COOH-DAB. Appearance of protein-metabolite adducts in bile were also observed after addition of normal bile proteins to the perfusate. The results suggest that uptake and metabolism of 3'-Me-DAB and biliary secretion of many of its metabolites occur in the absence of circulating blood protein; some metabolites may require proteins in the circulation for their secretion into bile.

UR - http://www.scopus.com/inward/record.url?scp=0023113787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023113787&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 184

EP - 188

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 2

ER -